z-logo
open-access-imgOpen Access
Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects
Author(s) -
Ling Yang,
Qi Shen,
Chao Hu,
Ying Wang,
Xiaoyan Zhu,
Shiqing Shu,
Zhu Luo
Publication year - 2022
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s387508
Subject(s) - pharmacokinetics , cmax , tolerability , medicine , metabolite , pharmacology , oral administration , cyclooxygenase , elderly people , area under the curve , population , adverse effect , chemistry , gerontology , biochemistry , enzyme , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here